|Posted by [email protected] on April 15, 2014 at 6:30 PM||comments (0)|
(Per Hepatitis Central:)
Fair or not, the cost of the new drugs is likely to keep them out of reach for most infected prisoners. To put the price in perspective, the average annual cost for states to house an inmate is $29,141. The minimal cost of treating a single patient with the new hepatitis C drugs is more than double that amount.
Continue reading this entire article:
|Posted by tigersandlions1[email protected] on February 25, 2014 at 10:40 AM||comments (0)|